Inactive Instrument
Probi AB Stock OTC Markets
Stocks
PBBIF
SE0001280355
Pharmaceuticals
OTC Markets Traded| 1 day | +31.67% |
| Manager | Title | Age | Since |
|---|---|---|---|
Anita Johansen
CEO | Chief Executive Officer | 54 | 2022-12-07 |
Johan Flink
DFI | Director of Finance/CFO | 49 | 2025-07-31 |
James Henson
COO | Chief Operating Officer | 39 | 2024-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jörn Andreas
BRD | Director/Board Member | 45 | 2013-12-31 |
| Chairman | 62 | 2015-03-31 | |
| Director/Board Member | 64 | 2017-05-03 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +31.67% | +85.88% | - | - | 33.68M | ||
| +4.37% | -3.88% | +51.84% | +156.13% | 995B | ||
| +0.99% | -3.25% | +50.46% | +48.41% | 614B | ||
| +2.20% | -5.65% | +25.11% | +65.25% | 431B | ||
| +1.66% | +0.53% | +42.36% | +37.29% | 353B | ||
| +0.51% | -3.51% | +31.12% | +39.32% | 293B | ||
| +3.25% | -8.02% | +7.66% | +10.97% | 245B | ||
| +6.50% | +6.40% | +37.45% | +63.06% | 210B | ||
| -4.00% | -12.66% | -3.48% | -45.90% | 210B | ||
| -2.42% | -0.59% | +17.33% | +63.57% | 168B | ||
| Average | +4.46% | -5.02% | +28.87% | +48.68% | 390.92B | |
| Weighted average by Cap. | +2.08% | -5.89% | +36.78% | +72.44% |
Employees
-
Sector
Pharmaceuticals
















